Search results
Results From The WOW.Com Content Network
lonza.com. Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development ...
The size of Lonza Group Ltd (VTX:LONN), a CHF22b large-cap, often attracts investors seeking a reliable investment in the stock market. Market participants who are conscious of risk tend to search ...
After Lonza Group Ltd's (VTX:LONN) earnings announcement in December 2018, analysts seem cautiously optimistic, as a...
July 25, 2024 at 12:19 AM. By Isabel Demetz and Andrey Sychev. (Reuters) -Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a ...
Genentech became a wholly owned subsidiary group of Roche on 25 March 2009. [27] Roche began vacating the NJ site in 2012, and sold it off in 2016. [28] Roche acquired Medingo Ltd. in April 2010, for $160 million [29] and BioImagene, Inc. in August for $100 million. [30]
Net income. US$5.357 billion (2023) ... the Lonza Group announced it would acquire Capsugel for $5.5 billion from Kohlberg Kravis ... reportedly worth US$883 million, ...
Lonza said its medium-term strategy and outlook would be discussed in detail at its capital markets day on Oct. 17 and that Chairman Albert Baehny would take on the CEO responsibilities until the ...
Sergio Marchionne (Italian: [ˈsɛrdʒo marˈkjɔnne]; 17 June 1952 – 25 July 2018) was an Italian-Canadian businessman, widely known for his turnarounds of the automakers Fiat and Chrysler, his business acumen and his outspoken and often frank approach, especially when dealing with unpalatable issues related to his companies and the automotive industry.